| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
|
Bertsias, George
|
|
|
6 |
11 |
p. e734-e735
|
artikel
|
| 2 |
Arthritis complicating inflammatory bowel disease— the future is now
|
Song, Kaiyang
|
|
|
6 |
11 |
p. e805-e810
|
artikel
|
| 3 |
Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials
|
Parodis, Ioannis
|
|
|
6 |
11 |
p. e751-e761
|
artikel
|
| 4 |
Calcium pyrophosphate deposition disease
|
Pascart, Tristan
|
|
|
6 |
11 |
p. e791-e804
|
artikel
|
| 5 |
Challenges and solutions for cellular therapy development in autoimmune diseases
|
Volkmann, Elizabeth R
|
|
|
6 |
11 |
p. e740-e743
|
artikel
|
| 6 |
Combinations of immunomodulatory agents for prevention of uveitis relapse in patients with severe Behçet's disease already on corticosteroid therapy: a randomised, open-label, head-to-head trial
|
Zhong, Zhenyu
|
|
|
6 |
11 |
p. e780-e790
|
artikel
|
| 7 |
Correction to Lancet Rheumatol 2024; 6: e507–17
|
|
|
|
6 |
11 |
p. e749
|
artikel
|
| 8 |
Correction to Lancet Rheumatol 2024; 6: e664–65
|
|
|
|
6 |
11 |
p. e749
|
artikel
|
| 9 |
Data-driven subclassification of ANCA-associated vasculitis: model-based clustering of a federated international cohort
|
Gisslander, Karl
|
|
|
6 |
11 |
p. e762-e770
|
artikel
|
| 10 |
Explanation for substandard of care comparators in rheumatology randomised trial protocols
|
Sheng, Jacky
|
|
|
6 |
11 |
p. e743-e745
|
artikel
|
| 11 |
Gout in central Asia: a few things make a big difference
|
Baimukhamedov, Chokan
|
|
|
6 |
11 |
p. e747-e748
|
artikel
|
| 12 |
Gout in central Asia: a few things make a big difference – Authors' reply
|
Cross, Marita
|
|
|
6 |
11 |
p. e748
|
artikel
|
| 13 |
Inclusion of pregnant populations in clinical trials in China: the ethical considerations
|
Chen, Xiaoyan
|
|
|
6 |
11 |
p. e746-e747
|
artikel
|
| 14 |
Inclusive study design to better serve the needs of children and young people with rheumatological conditions
|
Solebo, Ameenat Lola
|
|
|
6 |
11 |
p. e746
|
artikel
|
| 15 |
Reclassifying ANCA-associated vasculitis: a focus on kidney disease
|
Berke, Ilay
|
|
|
6 |
11 |
p. e736-e737
|
artikel
|
| 16 |
Research in Brief
|
Thorley, Jennifer
|
|
|
6 |
11 |
p. e750
|
artikel
|
| 17 |
The effects of age and frailty on the risks of end-stage renal disease, death, and severe infection in older adults with antineutrophil cytoplasmic antibody-associated vasculitis: a retrospective cohort study
|
Sattui, Sebastian E
|
|
|
6 |
11 |
p. e771-e779
|
artikel
|
| 18 |
The 2024 US election—voting for equitable health care
|
The Lancet Rheumatology,
|
|
|
6 |
11 |
p. e733
|
artikel
|
| 19 |
Treating antineutrophil cytoplasmic antibody-associated vasculitis in frail older adults
|
Legge, Alexandra
|
|
|
6 |
11 |
p. e737-e739
|
artikel
|
| 20 |
Uveitis relapse in Behçet's disease: a more nuanced approach is needed
|
Guan, Jian-long
|
|
|
6 |
11 |
p. e739-e740
|
artikel
|
Tijdschrift beschrijving